According to Beating Monitor’s tracking, court documents leaked through Musk’s lawsuit against OpenAI reveal that Sam Altman has created a wealth loop by leveraging OpenAI’s commercial contracts to inflate the valuations of his personal investments. Since Altman holds no equity in OpenAI, his financial returns depend entirely on external startups in which he has personal stakes. The mechanism of this wealth loop operates as follows: OpenAI signs procurement contracts or partnership agreements that boost the valuations of these startups, after which OpenAI’s major shareholders (such as Thrive Capital) or partners (such as SoftBank) acquire stakes at premium prices, directly enabling Altman’s personal wealth to surge. In June 2026, after Thrive Capital, a major shareholder of OpenAI, invested in the fusion company Helion at a $15.5 billion valuation, insiders revealed that Altman’s personal stake in Helion had more than doubled to at least $4.1 billion. In 2025, Altman had requested that OpenAI invest approximately $500 million in Helion, prompting concern among some employees; OpenAI subsequently declined the investment. However, in March 2026, the two parties signed a revised cooperation agreement, and Altman stepped down from Helion’s board that same month to avoid conflicts of interest. Additionally, after the chipmaker Cerebras secured a procurement commitment from OpenAI and successfully completed its IPO, the value of Altman’s stake in Cerebras surged more than sixfold since December 2025. Following a research collaboration between the longevity startup Retro Biosciences and OpenAI, evidence disclosed in Elon Musk’s lawsuit indicates that Altman’s stake in Retro was valued at $258 million as of December 2025. Currently, at least ten companies in which Altman has invested have related-party transactions with OpenAI. The U.S. House Oversight Committee has launched a formal investigation, and multiple state attorneys general have called on the Securities and Exchange Commission to review Altman’s activities.
Sam Altman's investment valuation surges through OpenAI connections
MarsBitShare
Summary
On-chain news reveals new details about Sam Altman’s investment strategy through court documents from Elon Musk’s lawsuit against OpenAI. Without holding OpenAI equity, Altman elevated startup valuations through OpenAI contracts with Helion, Cerebras, and Retro Biosciences. These agreements attracted major investors, including a $15.5 billion investment from Thrive Capital in Helion in June 2026, giving Altman a $4.1 billion stake. OpenAI had previously declined a $500 million investment in Helion in 2025. Altman stepped down from Helion’s board in March 2026 to avoid conflicts of interest. The U.S. House Oversight Committee is now investigating at least ten companies backed by Altman that are linked to OpenAI. Crypto news continues to follow this developing story.
Source:Show original
Disclaimer: The information on this page may have been obtained from third parties and does not necessarily reflect the views or opinions of KuCoin. This content is provided for general informational purposes only, without any representation or warranty of any kind, nor shall it be construed as financial or investment advice. KuCoin shall not be liable for any errors or omissions, or for any outcomes resulting from the use of this information.
Investments in digital assets can be risky. Please carefully evaluate the risks of a product and your risk tolerance based on your own financial circumstances. For more information, please refer to our Terms of Use and Risk Disclosure.